Related Experiment Video
Updated: Nov 16, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.3K
A greedy approach for mutual exclusivity analysis in cancer study
Hongyan Fang1, Zeyu Zhang2, Yinsheng Zhou2
1School of Mathematical Sciences, Anhui University, Hefei, Anhui, China.
Biostatistics (Oxford, England)
|February 26, 2021
Summary
Identifying cancer driver genes is challenging due to mutation heterogeneity. This study proposes a powerful, greedy algorithm to detect mutual exclusivity (ME) gene sets, aiding cancer driver gene discovery and understanding cancer progression.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Distinguishing driver genes from passenger mutations is a key challenge in cancer genomics.
- Cancer genomes display significant mutational heterogeneity, making driver identification complex.
- Mutual exclusivity (ME) patterns in somatic mutations are linked to functional pathways and may indicate driver genes.
Purpose of the Study:
- To develop a probabilistic, generative model for analyzing ME patterns in cancer data.
- To propose an efficient and powerful greedy algorithm for selecting ME gene sets.
- To enhance the understanding of cancer progression through ME analysis.
Main Methods:
- Developed a probabilistic, generative model for ME.
- Proposed a greedy algorithm incorporating pre-selection and stepwise forward selection.
- Reduced computational time significantly through the proposed algorithm.
- Validated the method's power for single and multiple overlapping ME sets.
Main Results:
- The proposed greedy algorithm is efficient and powerful for identifying ME gene sets.
- The method effectively analyzes ME patterns in complex cancer genomic data.
- Demonstrated utility by analyzing TCGA whole-exome sequencing data.
Conclusions:
- The developed probabilistic model and greedy algorithm offer a robust approach for ME gene set identification.
- This method can aid in discovering cancer driver genes and pathways.
- The findings contribute to a novel understanding of cancer progression mechanisms.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
523
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
523
01:20Comparing the Survival Analysis of Two or More Groups
402
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
402
01:24Kaplan-Meier Approach
382
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
382
01:15Assumptions of Survival Analysis
251
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
251
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
264
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
264